András serves as an Innovation and Investment expert at Syreon Research Institute joined to the REMEDi4ALL consortium to represent the Institute’s early Health Technology Asesment and Investor Support expertises . He has both consulting and industry side experience in the pharmaceutical and medical device space. He holds an MSc. degree in field of Health Policy, Planning and Financing from Eötvös Loránd University (Budapest).
Prior joining Syreon András has worked first in junior and mid-senior roles at international strategy consulting companies (PwC, Roland Berger) with a biopharma focus, and in the pharmaceutical industry (Gedeon Richter). Later he founded his own boutique consultancy company.
In terms of his project experience, he assisted major pharmaceutical companies in Hungary and in the DACH region in their strategy development, BD&L and product development related activities. His experience mainly covers biosimilars (Rheumatology, Immunology, Osteoporosis, Cell & Gene Therapy), and medical devices (drug-device combinations and digital medical devices).
